MARKET

MEDXF

MEDXF

Medexus Pharmace
OTCQX
2.100
+0.100
+5.00%
Closed 15:50 02/13 EST
OPEN
2.080
PREV CLOSE
2.000
HIGH
2.100
LOW
2.080
VOLUME
800
TURNOVER
1.68K
52 WEEK HIGH
2.620
52 WEEK LOW
1.450
MARKET CAP
42.29M
P/E (TTM)
125.75
1D
5D
1M
3M
1Y
5Y
1D
Medexus Pharmaceuticals reports Q3 results
Seeking Alpha · 4d ago
Medexus Pharmaceuticals Releases MD&A Report for Period Ended December 31, 2025
Reuters · 4d ago
Medexus reports Q3 net revenue of USD 25.3 million, down 15.7%
Reuters · 4d ago
Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
Newsfile · 4d ago
Weekly Report: what happened at MEDXF last week (0202-0206)?
Weekly Report · 6d ago
Medexus Pharmaceuticals Inc. kündigt Finanz-Update an
Reuters · 02/03 22:31
Medexus Pharmaceuticals Inc. to Host Conference Call on Third Fiscal Quarter Results
Reuters · 02/03 22:31
Medexus Schedules Third Fiscal Quarter 2026 Conference Call
Newsfile · 02/03 22:30
More
About MEDXF
Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of hematology-oncology and allergy, dermatology, and rheumatology. It operates through two product portfolios: Medexus Pharma Canada and Medexus Pharma. Its lead products are IXINITY (US), GRAFAPEX (US), Trecondyv (Canada), Rupall (Canada), Rasuvo (US), Metoject (Canada), and Gleolan (US). IXINITY (US) is an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B. Rupall (Canada) is a prescription allergy medication with a mode of action. Rasuvo (US) and Metoject (Canada) is a formulation of methotrexate designed to treat rheumatoid arthritis and other autoimmune diseases. Gleolan (US) is an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.

Webull offers Medexus Pharmaceuticals Inc stock information, including OTCQX: MEDXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDXF stock methods without spending real money on the virtual paper trading platform.